Social networks
32,195Activities
Technologies
Entity types
Location
9804 Medical Center Dr, Rockville, MD 20850, USA
Rockville
United States of America
Employees
Scale: 201-500
Estimated: 369
Engaged corporates
1Added in Motherbase
7 months, 2 weeks agoSeeking to improve lives through the curative potential of gene therapy.
REGENXBIO is a leading biotechnology company focused on the development, commercialization and licensing of recombinant adeno‐associated virus (AAV) gene therapy. REGENXBIO's NAV® Technology Platform, a proprietary AAV gene delivery platform, consists of exclusive rights to more than 100 novel AAV vectors, including AAV7, AAV8, AAV9 and AAVrh10. REGENXBIO's mission is to transform the lives of patients suffering from severe diseases with significant unmet medical need by developing and commercializing in vivo gene therapy products based on REGENXBIO's NAV Technology Platform. REGENXBIO seeks to accomplish this mission through a combination of internal development efforts and third‐party NAV Technology Platform licensees.
Biotechnology, Biopharmaceuticals, and Gene Therapy
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
![]() | SATT Aquitaine Science Transfert | Other 6 Feb 2024 | |